Lista de obras - Emmanuel Bachy - Dominio Público Uruguay

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.

artículo científico publicado en 2018

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.

artículo científico publicado en 2014

Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC.

artículo científico publicado en 2016

Anti-PD1 antibody: a new approach to treatment of lymphomas

artículo científico publicado en 2013

Are we nearing an era of chemotherapy-free management of indolent lymphoma?

artículo científico publicado en 2014

Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders

artículo científico publicado en 2016

Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party.

artículo científico publicado en 2015

Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study

artículo científico publicado en 2016

Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients

artículo científico publicado en 2015

CD1d-restricted peripheral T cell lymphoma in mice and humans

artículo científico publicado en 2016

Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts

artículo científico publicado en 2018

Chemotherapy-free treatment in patients with follicular lymphoma

artículo científico publicado en 2015

Chronic Borrelia burgdorferi infection triggers NKT lymphomagenesis

artículo científico publicado en 2018

Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming

artículo científico publicado en 2021

Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era

scientific article published on 30 January 2020

Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation

artículo científico publicado en 2007

Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study

artículo científico publicado en 2015

Combination therapy for relapsed peripheral T-cell lymphoma: is two better than one?

artículo científico publicado en 2015

Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients.

artículo científico publicado en 2016

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

artículo científico publicado en 2016

Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival

artículo científico publicado en 2012

Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA)

scientific article published on 21 September 2015

Extracorporeal cytokine adsorption for treating severe refractory cytokine release syndrome (CRS)

scientific article published on 10 April 2020

FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study

artículo científico publicado en 2017

Hepatitis C virus infection and lymphoma

artículo científico publicado en 2010

Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis.

artículo científico publicado en 2014

Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases

artículo científico publicado en 2013

Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy

artículo científico publicado en 2012

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.

artículo científico publicado en 2013

Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study

artículo científico publicado en 2017

Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma

artículo científico publicado en 2012

Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival.

artículo científico publicado en 2013

Marrow-ablative treatment and autologous stem cell transplantation in follicular NHL.

artículo científico publicado en 2011

Molecular Classification of Diffuse Large B-cell Lymphoma: What Is Clinically Relevant?

artículo científico publicado en 2016

Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study

artículo científico publicado en 2015

Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study

artículo científico publicado en 2016

Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemia

artículo científico publicado en 2015

Quantitative and functional analyses of CD4(+) CD25(+) FoxP3(+) regulatory T cells in chronic phase chronic myeloid leukaemia patients at diagnosis and on imatinib mesylate

scientific article published on 31 January 2011

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.

artículo científico publicado en 2017

Rapamycin safeguards lymphocytes from DNA damage accumulation in vivo.

artículo científico publicado en 2016

Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes

artículo científico publicado en 2018

Sarcoidosis and lymphoma: a comparative study.

artículo científico

Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia

scientific article published on 19 November 2019

Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study.

artículo científico publicado en 2016

Time has come for immunotherapy in PTCL.

artículo científico publicado en 2014

Treatment approach to newly diagnosed diffuse large B-cell lymphoma.

artículo científico

Use of Commercial anti-CD19 CAR T Cell Therapy for Patients with Relapsed/Refractory Aggressive B Cell Lymphoma in a European center

artículo científico publicado en 2020

What is the best first-line treatment strategy for patients with indolent lymphomas?

artículo científico publicado en 2012

[Prognostic factors in lymphomas]

scientific article published on 01 January 2010

Lista de obras de Emmanuel Bachy

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.

Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC.

Anti-PD1 antibody: a new approach to treatment of lymphomas

Are we nearing an era of chemotherapy-free management of indolent lymphoma?

Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders

Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party.

Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study

Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients

CD1d-restricted peripheral T cell lymphoma in mice and humans

Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts

Chemotherapy-free treatment in patients with follicular lymphoma

Chronic Borrelia burgdorferi infection triggers NKT lymphomagenesis

Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming

Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era

Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation

Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study

Combination therapy for relapsed peripheral T-cell lymphoma: is two better than one?

Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients.

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival

Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA)

Extracorporeal cytokine adsorption for treating severe refractory cytokine release syndrome (CRS)

FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study

Hepatitis C virus infection and lymphoma

Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis.

Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases

Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.

Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study

Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma

Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival.

Marrow-ablative treatment and autologous stem cell transplantation in follicular NHL.

Molecular Classification of Diffuse Large B-cell Lymphoma: What Is Clinically Relevant?

Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study

Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study

Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemia

Quantitative and functional analyses of CD4(+) CD25(+) FoxP3(+) regulatory T cells in chronic phase chronic myeloid leukaemia patients at diagnosis and on imatinib mesylate

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.

Rapamycin safeguards lymphocytes from DNA damage accumulation in vivo.

Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes

Sarcoidosis and lymphoma: a comparative study.

Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia

Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study.

Time has come for immunotherapy in PTCL.

Treatment approach to newly diagnosed diffuse large B-cell lymphoma.

Use of Commercial anti-CD19 CAR T Cell Therapy for Patients with Relapsed/Refractory Aggressive B Cell Lymphoma in a European center

What is the best first-line treatment strategy for patients with indolent lymphomas?

[Prognostic factors in lymphomas]